Analyst consensus rating
GSK Analyst Rating: Hold
Direct answer
GSK's consensus rating is Hold.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $58.58.
Forecast evidence checked September 8, 2026.
Get free GSK email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $48.54
- Average price target
- $58.58
- High price target
- $70.00
- Low price target
- $50.00
- Low target gap
- +3%
- Target upside
- +20.7%
- High target gap
- +44.2%
- Target range width
- 41.2%
- Consensus rating
- Hold
- Analysts
- 8
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for GSK?
GSK has a verified Hold consensus. The same dataset has an average price target of $58.58.
How far are GSK's low and high targets from the recorded price?
The low target implies +3%, while the high target implies +44.2%.
How many analysts are included in GSK's consensus?
The verified consensus includes 8 analysts.
How is GSK's target upside or downside calculated?
The average target of $58.58 is divided by the recorded price of $48.54, then one is subtracted to produce +20.7%. This does not guarantee a future return.
When was GSK's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.